A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia University have created an artificial intelligence model that can predict which ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

CDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK ...

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

Fractyl Health is deprioritizing a type 2 diabetes trial in favor of a pivotal study of its endoscopy treatment Revita and ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

In the ever-evolving field of longevity and anti-aging research, chemical sciences are making significant strides, ...

Vertex Pharmaceuticals (VRTX) stock gains as England opts to reimburse its CRSPR (CRSP)-partnered gene therapy Casgevy to ...

BOISE — Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause on certain types of vaccines that were used ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...